BUZZ-U.S. Stocks on the Move-Bristol-Meyers, Cubist Pharma, CBS

lunes 8 de diciembre de 2014 08:54 GYT
 

Dec 8 - (For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures dipped on Monday, indicating the S&P 500 may retreat from a record high, as soft data in China and Japan stoked global growth concerns. Dow Jones industrial average futures were down 0.27 percent at 17,904, S&P 500 futures were down 0.30 percent at 2,069.75 and Nasdaq 100 futures were down 0.30 percent at 4,300.25.

** BRISTOL-MYERS SQUIBB CO, Friday close $60.65, +0.97 pct premarket

Eighty-seven percent of Hodgkin lymphoma patients responded to a Bristol-Myers Squibb drug that helps the immune system fight the blood cancer, according to data from a small, early stage trial released on Saturday.

** MERCK & CO INC, Friday close $61.49, -0.05 pct premarket

** CUBIST PHARMACEUTICALS INC, Friday close $74.36, +35.97 pct premarket

Merck said on Monday it would buy Cubist Pharmaceuticals in a deal valued at $9.5 billion, giving the major drugmaker an entry into the market for drugs that target so-called superbugs.

  Continuación...